Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 7, pp. 1506-1519
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 14, 2019
- Revision received November 20, 2019
- Accepted May 1, 2020
- Published first May 5, 2020.
Article Versions
- Previous version (May 5, 2020 - 07:57).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Mégane Vernon1,2,
- Bernard Lambert1,2,3,
- Matthieu Meryet-Figuière1,2,
- Emilie Brotin1,2,4,
- Louis-Bastien Weiswald1,2,
- Hippolyte Paysant1,2,
- Nicolas Vigneron1,2,
- Anaïs Wambecke1,2,
- Edwige Abeilard1,2,4,
- Florence Giffard1,2,
- Marie-Hélène Louis1,2,
- Cécile Blanc-Fournier1,2,5,
- Pascal Gauduchon1,2,
- Laurent Poulain1,2,4, and
- Christophe Denoyelle1,2,4,*
- 1Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE (Interdisciplinary Research Unit for the Prevention and Treatment of Cancer), Biology and Innovative Therapies of Ovarian Cancers (BioTICLA), Caen, France.
- 2UNICANCER, Cancer Center François Baclesse, Caen, France.
- 3CNRS, Normandy Regional Delegation, Caen, France.
- 4ImpedanCELL core facility, Federative Structure 4206 ICORE, UNICAEN, Caen, France.
- 5Biopathology Department, UNICANCER, Cancer Center F. Baclesse, Caen, France.
- ↵*Corresponding Author:
Christophe Denoyelle, Inserm U1086 ANTICIPE, Research building, François Baclesse Cancer Center, 3 Avenue Général Harris BP 45026, 14 076 Caen cedex 05, France. Phone: 330-231-5171; Fax: 330-23145-5172; E-mail: c.denoyelle{at}baclesse.unicancer.fr
July 2020
Volume 19, Issue 7
Volume 19, Issue 7
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids
Jump to section
Advertisement